Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998050015) DRY POWDER INHALER EXCIPIENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/050015 International Application No.: PCT/BE1998/000064
Publication Date: 12.11.1998 International Filing Date: 07.05.1998
IPC:
A61K 47/26 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
26
Carbohydrates
Applicants:
PHARLYSE, SOCIETE ANONYME [LU/LU]; 2, boulevard Royal L-Luxembourg, LU (AllExceptUS)
VANDERBIST, Francis [BE/BE]; BE (UsOnly)
MAES, Paul [BE/BE]; BE (UsOnly)
BAUDIER, Philippe [BE/BE]; BE (UsOnly)
Inventors:
VANDERBIST, Francis; BE
MAES, Paul; BE
BAUDIER, Philippe; BE
Agent:
SCHMITZ, Yvon ; Gevers Patents Holidaystraat 5 B-1831 Diegem, BE
Priority Data:
97870065.607.05.1997EP
Title (EN) DRY POWDER INHALER EXCIPIENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
(FR) EXCIPIENT POUR INHALATEUR A POUDRE SECHE, SON PROCEDE DE PREPARATION, ET COMPOSITIONS PHARMACEUTIQUES LE CONTENANT
Abstract:
(EN) A pharmaceutical excipient useful in the formulation of dry powder inhaler compositions comprising a particulate roller-dried anhydrous $g(b)-lactose, said $g(b)-lactose particles having a size between 50 and 250 micrometers and a rugosity between 1.9 and 2.4, and the so formulated pharmaceutical compositions.
(FR) L'invention concerne un excipient pharmaceutique utile dans la formulation de compositions pour inhalateurs à poudre sèche, comprenant du $g(b)-lactose anhydre particulaire séché dans des cylindres. Les particules de $g(b)-lactose ont une taille comprise entre 50 et 250 $g(m)m et une rugosité comprise entre 1,9 et 2,4. L'invention concerne également les compositions pharmaceutiques ainsi formulées.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0876814EP0964675US7090870CA2287333AU1998072012